KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.51M | 18.34M | 18.76M | 19.31M | 19.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.31M | 40.43M | 40.32M | 41.25M | 40.86M |
| Operating Income | -39.31M | -40.43M | -40.32M | -41.25M | -40.86M |
| Income Before Tax | -35.65M | -38.51M | -38.96M | -38.72M | -39.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.65 | -38.51 | -38.96 | -38.72 | -39.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.65M | -38.51M | -38.96M | -38.72M | -39.55M |
| EBIT | -39.31M | -40.43M | -40.32M | -41.25M | -40.86M |
| EBITDA | -39.05M | -40.18M | -40.06M | -40.98M | -40.57M |
| EPS Basic | -8.25 | -11.03 | -12.47 | -13.95 | -15.15 |
| Normalized Basic EPS | -5.10 | -6.81 | -6.86 | -8.27 | -8.92 |
| EPS Diluted | -8.25 | -11.03 | -12.47 | -13.95 | -15.15 |
| Normalized Diluted EPS | -5.10 | -6.81 | -6.86 | -8.27 | -8.92 |
| Average Basic Shares Outstanding | 18.70M | 15.17M | 13.18M | 11.11M | 10.46M |
| Average Diluted Shares Outstanding | 18.70M | 15.17M | 13.18M | 11.11M | 10.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |